StonvexLoading…
StonvexStonvexStonvexCore line items from CPRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-29 | Annual 2024 2024-03-30 | Annual 2023 2023-04-01 | Annual 2022 2022-04-02 |
|---|---|---|---|---|
Revenue | $4.44B | $5.17B | $5.62B | $5.65B |
Operating Income | $-752.00M | $-241.00M | $679.00M | $903.00M |
Net Income | $-1.18B | $-229.00M | $616.00M | $822.00M |
EPS (Diluted) | $-10.00 | $-1.96 | $4.60 | $5.39 |
Total Assets | $5.21B | $6.69B | $7.29B | $7.48B |
Total Liabilities | $4.84B | $5.09B | $5.45B | $4.92B |
Cash & Equivalents | $166.00M | $199.00M | $249.00M | $169.00M |
Free Cash Flow OCF − CapEx | $153.00M | $120.00M | $545.00M | $573.00M |
Shares Outstanding | 117.91M | 116.63M | 117.35M | 142.81M |